These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. An exploration of genetic counselors' needs and experiences with prenatal chromosomal microarray testing. Bernhardt BA; Kellom K; Barbarese A; Faucett WA; Wapner RJ J Genet Couns; 2014 Dec; 23(6):938-47. PubMed ID: 24569858 [TBL] [Abstract][Full Text] [Related]
8. "It's probably nothing, but…" Couples' experiences of pregnancy following an uncertain prenatal genetic result. Lou S; Lomborg K; Lewis C; Riedijk S; Petersen OB; Vogel I Acta Obstet Gynecol Scand; 2020 Jun; 99(6):791-801. PubMed ID: 31955407 [TBL] [Abstract][Full Text] [Related]
9. Information Women Choose to Receive About Prenatal Chromosomal Microarray Analysis. Hochner H; Daum H; Douiev L; Zvi N; Frumkin A; Macarov M; Kimchi-Shaal A; Hacohen N; Eilat A; Faham D; Shkedi-Rafid S Obstet Gynecol; 2020 Jan; 135(1):149-157. PubMed ID: 31809435 [TBL] [Abstract][Full Text] [Related]
10. The Psychological Impact of Prenatal Diagnosis and Disclosure of Susceptibility Loci: First Impressions of Parents' Experiences. van der Steen SL; Riedijk SR; Verhagen-Visser J; Govaerts LC; Srebniak MI; Van Opstal D; Joosten M; Knapen MF; Tibben A; Diderich KE; Galjaard RJ J Genet Couns; 2016 Dec; 25(6):1227-1234. PubMed ID: 27220741 [TBL] [Abstract][Full Text] [Related]
11. Clinicians' attitudes towards parental choice in the era of advanced genomic tests in pregnancy. Macarov M; Meiner V; Chalk M; Hochner H; Shkedi-Rafid S Prenat Diagn; 2021 Aug; 41(9):1066-1073. PubMed ID: 34259341 [TBL] [Abstract][Full Text] [Related]
12. How are uncertain prenatal genetic results perceived and managed two years after they were received? A qualitative interview study. Lou S; Jensen AH; Vogel I J Genet Couns; 2021 Aug; 30(4):1191-1202. PubMed ID: 33830585 [TBL] [Abstract][Full Text] [Related]
13. To offer or request? Disclosing variants of uncertain significance in prenatal testing. Watts G; Newson AJ Bioethics; 2021 Nov; 35(9):900-909. PubMed ID: 34415629 [TBL] [Abstract][Full Text] [Related]
15. Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada. Armour CM; Dougan SD; Brock JA; Chari R; Chodirker BN; DeBie I; Evans JA; Gibson WT; Kolomietz E; Nelson TN; Tihy F; Thomas MA; Stavropoulos DJ; J Med Genet; 2018 Apr; 55(4):215-221. PubMed ID: 29496978 [TBL] [Abstract][Full Text] [Related]
16. "Something Extra on Chromosome 5": Parents' Understanding of Positive Prenatal Chromosomal Microarray Analysis (CMA) Results. Walser SA; Werner-Lin A; Russell A; Wapner RJ; Bernhardt BA J Genet Couns; 2016 Oct; 25(5):1116-26. PubMed ID: 26940446 [TBL] [Abstract][Full Text] [Related]
18. Prenatal diagnosis of susceptibility loci for neurodevelopmental disorders - genetic counseling and pregnancy outcome in 57 cases. Govaerts L; Srebniak M; Diderich K; Joosten M; Riedijk S; Knapen M; Go A; Papatsonis D; de Graaf K; Toolenaar T; van der Steen S; Huijbregts G; Knijnenburg J; de Vries F; Van Opstal D; Galjaard RJ Prenat Diagn; 2017 Jan; 37(1):73-80. PubMed ID: 27931090 [TBL] [Abstract][Full Text] [Related]
19. Factors affecting Thai pregnant women's decisions concerning prenatal diagnosis and termination of pregnancy for β-thalassemia. Phaophan A; Mongkolchat N; Chuenwattana P; Viboonchart S J Obstet Gynaecol Res; 2021 Feb; 47(2):631-639. PubMed ID: 33432716 [TBL] [Abstract][Full Text] [Related]
20. Facilitating autonomous, confident and satisfying choices: a mixed-method study of women's choice-making in prenatal screening for common aneuploidies. Chen A; Tenhunen H; Torkki P; Peltokorpi A; Heinonen S; Lillrank P; Stefanovic V BMC Pregnancy Childbirth; 2018 May; 18(1):119. PubMed ID: 29720125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]